Skip to main content
. Author manuscript; available in PMC: 2022 Mar 11.
Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 2;184(3):689–698. doi: 10.1007/s10549-020-05884-z

Table 2.

Patient characteristics of high-grade serous ovarian cancer cohort

Factors RNA-seq (N = 314)
N (%)
Age 59 (30, 87)
 Median (min, max)
Race 269 (86%)
 White
 Black 23 (7%)
 Asian 9 (3%)
 Others or unknown 13 (4%)
Clinical stage
 I 1 (0%)
 II 21 (7%)
 III 292 (93%)
Grade
 G2 35 (11%)
 G3 273 (87%)
 GX 6 (2%)
DFI
Event 126 (40%)
Event-free 50 (16%)
Unknown 138 (44%)
PFI
Event 227 (72%)
Event-free 87 (28%)